Primary Use of the TruePath Crossing Device for Infrainguinal Chronic Total Occlusions With Intravascular Ultrasound Evaluation.

Yoshimitsu SogaMiho NakamuraKaoru HiroseNobuhiro ItoYusuke TomoiSeiichi HiramoriKenji Ando

Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2018)

Primary use of the TruePath crossing device for infrainguinal CTOs demonstrated a satisfactory complete success rate and a high rate of IVUS-documented intraluminal crossing with few device-related complications. Severe calcification is an independent predictor of TruePath failure.

Keyphrases

magnetic resonance imaging
coronary artery
chronic kidney disease
risk factors
early onset
drug induced
ultrasound guided